Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_129e393582e6bdf4029baf2206522f45 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-732 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-23 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-303 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-486 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6859 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30 |
filingDate |
2013-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2016-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8cc0528072c4ddfb3545aae484fe76b2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bff695bcb240f2403f6645eb83e98861 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_467c6274346dc6e8c575321730800725 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_460165f957f4c227939af9af95aec99d |
publicationDate |
2016-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-9416193-B2 |
titleOfInvention |
Pharmaceutical composition for treatment and/or prevention of liver cancer |
abstract |
Provided is an antibody effective for treatment and/or prevention of liver cancer. A pharmaceutical composition for treatment and/or prevention of liver cancer contains as an active ingredient an antibody or a fragment thereof having immunological reactivity with a CAPRIN-1 protein or a fragment thereof comprising at least seven consecutive amino acid residues of the amino acid sequence of the protein. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10675358-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11547761-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9982059-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11110178-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9862774-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016208014-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9796775-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11137401-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11400164-B2 |
priorityDate |
2012-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |